Biotech · Private company
Prothena Biosciences Ltd.
Track this companyFree. Adds Prothena Biosciences Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials123 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- BirtamimabPhase 3 · Light Chain (AL) AmyloidosisClinicalTrials.gov · fetched Nov 12, 2026
- NEOD001Phase 3 · Primary Systemic (AL) AmyloidosisClinicalTrials.gov · fetched Nov 12, 2026
- NEOD001Phase 2 · AL AmyloidosisClinicalTrials.gov · fetched Nov 12, 2026
- PRX004Phase 1 · Amyloidogenic Transthyretin (ATTR) AmyloidosisClinicalTrials.gov · fetched Nov 12, 2026
- PRX019Phase 1 · Healthy Participants StudyClinicalTrials.gov · fetched Nov 12, 2026
- non-interventionalAL AmyloidosisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials12
- A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's DiseasePHASE3 · RECRUITING · started Nov 24, 2025ClinicalTrials.gov NCT07174310 · fetched Nov 12, 2026
- Phase 1 Study of PRX019 in Healthy Adult VolunteersPHASE1 · COMPLETED · started Nov 8, 2024ClinicalTrials.gov NCT06699680 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy and Safety of Birtamimab in Mayo Stage IV Patients With AL AmyloidosisPHASE3 · TERMINATED · started Aug 30, 2021ClinicalTrials.gov NCT04973137 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's DiseasePHASE2 · ACTIVE_NOT_RECRUITING · started May 5, 2021ClinicalTrials.gov NCT04777331 · fetched Nov 12, 2026
- A Study of PRX004 in Subjects With Amyloid Transthyretin (ATTR) AmyloidosisPHASE1 · TERMINATED · started Apr 5, 2018ClinicalTrials.gov NCT03336580 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's DiseasePHASE2 · ACTIVE_NOT_RECRUITING · started Jun 27, 2017ClinicalTrials.gov NCT03100149 · fetched Nov 12, 2026
- Study in Subjects With Light Chain (AL) AmyloidosisPHASE2 · TERMINATED · started Jun 14, 2017ClinicalTrials.gov NCT03154047 · fetched Nov 12, 2026
- Cutaneous Autonomic Pilomotor Testing to Unveil the Role of Neuropathy Progression in Early Parkinson's DiseaseCOMPLETED · started Jun 1, 2016ClinicalTrials.gov NCT03043768 · fetched Nov 12, 2026
- The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) AmyloidosisPHASE2 · COMPLETED · started Mar 1, 2016ClinicalTrials.gov NCT02632786 · fetched Nov 12, 2026
- Open-label Extension Study of NEOD001 in Subjects With Light Chain (AL) AmyloidosisPHASE2 · TERMINATED · started Feb 1, 2016ClinicalTrials.gov NCT02613182 · fetched Nov 12, 2026
- Quality of Life (QOL) Registry for Patients With AL AmyloidosisCOMPLETED · started Oct 1, 2015ClinicalTrials.gov NCT02574676 · fetched Nov 12, 2026
- The VITAL Amyloidosis Study, a Global Phase 3, Efficacy and Safety Study of NEOD001 in Patients With AL AmyloidosisPHASE3 · TERMINATED · started Feb 1, 2015ClinicalTrials.gov NCT02312206 · fetched Nov 12, 2026